Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mirati Therapeutics Inc | 180,000 | 1,558,059 | +1,378,059 | $7.84M | $91.54M | 8.46% | +$83.70M |
| Immunogen Inc | 1,500,000 | 2,199,137 | +699,137 | $23.80M | $65.20M | 6.02% | +$41.40M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,140,586 | 2,204,797 | +64,211 | $38.04M | $44.65M | 4.13% | +$6.61M |
| Kalvista Pharmaceuticals Inc | 3,440,345 | 3,440,345 | 0 | $33.13M | $42.14M | 3.89% | +$9.01M |
| LianMedicalADS(LIANY) | 1,800,000 | 9,366,783 | +7,566,783 | $2.68M | $41.87M | 3.87% | +$39.19M |
| Anaptysbio Inc | 1,950,609 | 1,950,609 | 0 | $35.03M | $41.78M | 3.86% | +$6.75M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,137,107 | 1,137,107 | 0 | $35.93M | $33.57M | 3.10% | -$2.37M |
| Evolus, Inc.(EOLS) | 3,097,399 | 3,097,399 | 0 | $28.31M | $32.62M | 3.01% | +$4.31M |
| Altimmune, Inc.(ALT) | 2,750,000 | 2,750,000 | 0 | $7.15M | $30.94M | 2.86% | +$23.79M |
| Immunocore Holdings plcADS(IMCR) | 405,600 | 405,600 | 0 | $21.05M | $27.71M | 2.56% | +$6.66M |
| Axsome Therapeutics, Inc.(AXSM) | 320,000 | 320,000 | 0 | $22.36M | $25.47M | 2.35% | +$3.10M |
| PTC Therapeutics, Inc.(PTCT) | 0 | 900,000 | +900,000 | $0 | $24.80M | 2.29% | +$24.80M |
| Gracell Biotechnologies IncADS | 159,087 | 2,191,417 | +2,032,330 | $458.2K | $22.00M | 2.03% | +$21.54M |
| Revolution Medicines, Inc.(RVMD) | 0 | 679,630 | +679,630 | $0 | $19.49M | 1.80% | +$19.49M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 300,000 | 0 | $15.29M | $18.84M | 1.74% | +$3.55M |
| Eli Lilly and Company(LLY) | 30,000 | 30,000 | 0 | $16.11M | $17.49M | 1.62% | +$1.37M |
| New York Cmnty Bancorp Inc | 1,606,600 | 1,606,600 | 0 | $18.22M | $16.44M | 1.52% | -$1.78M |
| Intra-Cellular Therapies Inc | 300,000 | 220,000 | -80,000 | $15.63M | $15.76M | 1.46% | +$129.4K |
| BeOne Medicines AGADR(ONC) | 85,000 | 85,000 | 0 | $15.29M | $15.33M | 1.42% | +$41.6K |
| Avadel Pharmaceuticals PlcADR | 1,000,000 | 1,079,528 | +79,528 | $10.30M | $15.24M | 1.41% | +$4.94M |
| Viridian Therapeutics, Inc.(VRDN) | 669,125 | 692,925 | +23,800 | $10.26M | $15.09M | 1.39% | +$4.83M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 0 | 215,000 | +215,000 | $0 | $13.46M | 1.24% | +$13.46M |
| Theseus Pharmaceuticals Inc | 0 | 3,255,026 | +3,255,026 | $0 | $13.18M | 1.22% | +$13.18M |
| Atea Pharmaceuticals, Inc.(AVIR) | 3,600,000 | 4,076,741 | +476,741 | $10.80M | $12.43M | 1.15% | +$1.63M |
| AstraZeneca PLCADR(AZN) | 170,000 | 170,000 | 0 | $11.51M | $11.45M | 1.06% | -$62.9K |
| Zymeworks Inc.(ZYME) | 1,100,000 | 1,100,000 | 0 | $6.97M | $11.43M | 1.06% | +$4.46M |
| GSK plcADR(GSK) | 0 | 300,000 | +300,000 | $0 | $11.12M | 1.03% | +$11.12M |
| Kiniksa Pharmaceuticals LtdCL A | 600,000 | 600,000 | 0 | $10.42M | $10.52M | 0.97% | +$102.0K |
| CytomX Therapeutics, Inc.(CTMX) | 6,450,000 | 6,550,000 | +100,000 | $8.32M | $10.15M | 0.94% | +$1.83M |
| Ionis Pharmaceuticals, Inc.(IONS) | 200,000 | 200,000 | 0 | $9.07M | $10.12M | 0.93% | +$1.05M |
| Beam Therapeutics Inc.(BEAM) | 0 | 350,000 | +350,000 | $0 | $9.53M | 0.88% | +$9.53M |
| Cytokinetics, Incorporated(CYTK) | 0 | 110,000 | +110,000 | $0 | $9.18M | 0.85% | +$9.18M |
| Ascendis Pharma A/SADR(ASND) | 10,000 | 70,000 | +60,000 | $936.4K | $8.82M | 0.81% | +$7.88M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 271,200 | 271,200 | 0 | $8.89M | $8.76M | 0.81% | -$127.5K |
| Cymabay Therapeutics Inc | 200,000 | 350,000 | +150,000 | $2.98M | $8.27M | 0.76% | +$5.29M |
| Iovance Biotherapeutics, Inc.(IOVA) | 0 | 1,000,000 | +1,000,000 | $0 | $8.13M | 0.75% | +$8.13M |
| Cullinan Therapeutics, Inc.(CGEM) | 621,138 | 771,138 | +150,000 | $5.62M | $7.86M | 0.73% | +$2.24M |
| Moderna, Inc.(MRNA) | 76,700 | 76,700 | 0 | $7.92M | $7.63M | 0.70% | -$294.5K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 150,000 | 250,000 | +100,000 | $3.07M | $7.49M | 0.69% | +$4.42M |
| Graphite Bio Inc | 2,016,626 | 2,491,780 | +475,154 | $5.00M | $6.53M | 0.60% | +$1.53M |
| BioAtla, Inc.(BCAB) | 3,778,393 | 2,524,076 | -1,254,317 | $6.42M | $6.21M | 0.57% | -$214.0K |
| Kinnate Biopharma Inc | 0 | 2,601,647 | +2,601,647 | $0 | $6.17M | 0.57% | +$6.17M |
| Adma Biologics Inc | 1,360,000 | 1,360,000 | 0 | $4.87M | $6.15M | 0.57% | +$1.28M |
| Intellia Therapeutics, Inc.(NTLA) | 397,600 | 200,000 | -197,600 | $12.57M | $6.10M | 0.56% | -$6.47M |
| CVB Financial Corp.(CVBF) | 200,000 | 300,000 | +100,000 | $3.31M | $6.06M | 0.56% | +$2.74M |
| Verastem, Inc.(VSTM) | 891,514 | 741,514 | -150,000 | $7.25M | $6.04M | 0.56% | -$1.21M |
| Biohaven Ltd.(BHVN) | 140,000 | 140,000 | 0 | $3.64M | $5.99M | 0.55% | +$2.35M |
| Equity ComwlthCOM SH BEN INT | 300,000 | 300,000 | 0 | $5.51M | $5.76M | 0.53% | +$249.0K |
| Esperion Therapeutics Inc Ne | 1,850,000 | 1,850,000 | 0 | $1.81M | $5.53M | 0.51% | +$3.72M |
| Reneo Pharmaceuticals Inc | 0 | 3,330,000 | +3,330,000 | $0 | $5.33M | 0.49% | +$5.33M |
| Nuvation Bio Inc.CL A(NUVB) | 0 | 3,500,000 | +3,500,000 | $0 | $5.29M | 0.49% | +$5.29M |
| Dianthus Therapeutics, Inc.(DNTH) | 591,636 | 504,242 | -87,394 | $8.09M | $5.24M | 0.48% | -$2.84M |
| Bio Rad Labs IncCL A | 24,000 | 16,000 | -8,000 | $8.60M | $5.17M | 0.48% | -$3.44M |
| Insmed Incorporated(INSM) | 166,203 | 166,203 | 0 | $4.20M | $5.15M | 0.48% | +$954.0K |
| Black Diamond Therapeutics I | 400,000 | 1,803,200 | +1,403,200 | $1.15M | $5.07M | 0.47% | +$3.92M |
| Aurinia Pharmaceuticals Inc.(AUPH) | 750,000 | 550,000 | -200,000 | $5.83M | $4.94M | 0.46% | -$883.0K |
| Ventyx Biosciences Inc | 0 | 2,000,000 | +2,000,000 | $0 | $4.94M | 0.46% | +$4.94M |
| Veritex Hldgs Inc | 210,000 | 210,000 | 0 | $3.77M | $4.89M | 0.45% | +$1.12M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,800,000 | 800,000 | -1,000,000 | $12.74M | $4.79M | 0.44% | -$7.95M |
| Rain Oncology Inc | 3,740,341 | 3,850,513 | +110,172 | $3.22M | $4.62M | 0.43% | +$1.40M |
| Blueprint Medicines Corp | 0 | 50,000 | +50,000 | $0 | $4.61M | 0.43% | +$4.61M |
| U.S. Bancorp(USB) | 100,000 | 100,000 | 0 | $3.31M | $4.33M | 0.40% | +$1.02M |
| Dynavax Technologies Corp | 300,000 | 300,000 | 0 | $4.43M | $4.19M | 0.39% | -$237.0K |
| Bolt Biotherapeutics Inc | 3,557,040 | 3,652,244 | +95,204 | $3.70M | $4.09M | 0.38% | +$391.2K |
| uniQure N.V.SHS(QURE) | 935,800 | 600,000 | -335,800 | $6.28M | $4.06M | 0.38% | -$2.22M |
| Design Therapeutics, Inc.(DSGN) | 1,350,000 | 1,480,675 | +130,675 | $3.19M | $3.92M | 0.36% | +$737.8K |
| Cargo Therapeutics Inc | 0 | 160,544 | +160,544 | $0 | $3.72M | 0.34% | +$3.72M |
| Springworks Therapeutics Inc | 0 | 100,000 | +100,000 | $0 | $3.65M | 0.34% | +$3.65M |
| Nkarta, Inc.(NKTX) | 1,103,638 | 550,000 | -553,638 | $1.53M | $3.63M | 0.34% | +$2.10M |
| Bank Hawaii Corp | 30,000 | 50,000 | +20,000 | $1.49M | $3.62M | 0.33% | +$2.13M |
| Acadia Pharmaceuticals Inc | 100,000 | 114,400 | +14,400 | $2.08M | $3.58M | 0.33% | +$1.50M |
| Century Therapeutics, Inc.(IPSC) | 0 | 1,066,440 | +1,066,440 | $0 | $3.54M | 0.33% | +$3.54M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,166,954 | 4,387,238 | -779,716 | $4.03M | $3.48M | 0.32% | -$551.1K |
| IRulya Therapeutics Inc.(IRLA) | 3,498,868 | 3,220,000 | -278,868 | $3.92M | $3.38M | 0.31% | -$537.7K |
| Arvinas, Inc.(ARVN) | 80,000 | 80,000 | 0 | $1.57M | $3.29M | 0.30% | +$1.72M |
| Karuna Therapeutics Inc | 10,000 | 10,000 | 0 | $1.69M | $3.17M | 0.29% | +$1.47M |
| Heron Therapeutics, Inc.(HRTX) | 1,850,000 | 1,850,000 | 0 | $1.91M | $3.15M | 0.29% | +$1.24M |
| InflaRx N.V.(IFRX) | 2,824,353 | 1,873,753 | -950,600 | $8.42M | $3.05M | 0.28% | -$5.36M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 200,000 | +200,000 | $0 | $2.94M | 0.27% | +$2.94M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 0 | 300,000 | +300,000 | $0 | $2.82M | 0.26% | +$2.82M |
| Athira Pharma Inc | 352,715 | 1,152,715 | +800,000 | $712.5K | $2.80M | 0.26% | +$2.09M |
| Amarin Corp PlcADR | 5,862,517 | 3,086,544 | -2,775,973 | $5.39M | $2.69M | 0.25% | -$2.71M |
| Fate Therapeutics, Inc.(FATE) | 700,000 | 700,000 | 0 | $1.48M | $2.62M | 0.24% | +$1.13M |
| Seres Therapeutics, Inc.(MCRB) | 0 | 1,792,888 | +1,792,888 | $0 | $2.51M | 0.23% | +$2.51M |
| Passage Bio, Inc.(PASG) | 400,000 | 2,400,000 | +2,000,000 | $263.2K | $2.42M | 0.22% | +$2.16M |
| Enzo Biochem Inc | 2,200,000 | 1,700,000 | -500,000 | $3.08M | $2.36M | 0.22% | -$717.0K |
| Bluebird Bio Inc | 4,282,827 | 1,700,000 | -2,582,827 | $13.02M | $2.35M | 0.22% | -$10.67M |
| ARS Pharmaceuticals, Inc.(SPRY) | 409,463 | 409,463 | 0 | $1.55M | $2.24M | 0.21% | +$696.1K |
| Editas Medicine, Inc.(EDIT) | 200,000 | 200,000 | 0 | $1.56M | $2.03M | 0.19% | +$466.0K |
| ServisFirst Bancshares, Inc.(SFBS) | 30,000 | 30,000 | 0 | $1.57M | $2.00M | 0.18% | +$433.8K |
| PDS Biotechnology Corporation(PDSB) | 400,000 | 400,000 | 0 | $2.02M | $1.99M | 0.18% | -$32.0K |
| Tango Therapeutics, Inc.(TNGX) | 200,000 | 200,000 | 0 | $2.25M | $1.98M | 0.18% | -$272.0K |
| Elevation Oncology Inc | 4,000,000 | 3,667,600 | -332,400 | $2.65M | $1.97M | 0.18% | -$680.9K |
| Lite Strategy, Inc.(LITS) | 326,084 | 326,084 | 0 | $2.29M | $1.89M | 0.17% | -$394.6K |
| Genfit S AADS | 1,040,636 | 479,441 | -561,195 | $3.40M | $1.85M | 0.17% | -$1.56M |
| Aclaris Therapeutics, Inc.(ACRS) | 0 | 1,753,335 | +1,753,335 | $0 | $1.84M | 0.17% | +$1.84M |
| TG Therapeutics, Inc.(TGTX) | 100,000 | 100,000 | 0 | $836.0K | $1.71M | 0.16% | +$872.0K |
| Adicet Bio Inc | 1,226,352 | 876,352 | -350,000 | $1.68M | $1.66M | 0.15% | -$23.8K |
| Aligos Therapeutics Inc | 3,329,048 | 2,189,847 | -1,139,201 | $2.49M | $1.45M | 0.13% | -$1.03M |
| Lava Therapeutics NvSHS | 0 | 840,593 | +840,593 | $0 | $1.33M | 0.12% | +$1.33M |